Related Experiment Video
Updated: Jul 2, 2025

Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays
Published on: September 20, 2024
Host-Microbe Multiomic Profiling Reveals Age-Dependent COVID-19 Immunopathology
Hoang Van Phan1, Alexandra Tsitsiklis1, Cole P Maguire2
1University of California San Francisco.
Insights
Aging impairs immune responses to COVID-19, increasing viral load and inflammation. Older adults show delayed viral clearance and dysregulated immune signaling, highlighting potential therapeutic targets for severe coronavirus disease-2019.
Area of Science:
- Immunology
- Virology
- Gerontology
Background:
- Age is a significant risk factor for severe COVID-19, but the underlying immune mechanisms are not fully understood.
- Investigating age-related immune dysregulation is crucial for understanding COVID-19 severity and developing targeted therapies.
Approach:
- Analyzed blood and nasal samples from 1,031 hospitalized COVID-19 patients (18-96 years).
- Measured viral load, immune cell populations, inflammatory markers, and autoantibodies.
- Utilized transcriptomics, metatranscriptomics, and mass cytometry for comprehensive profiling.
Key Points:
- Older age correlated with higher SARS-CoV-2 viral load and slower viral clearance.
- Aging led to increased type I interferon and pro-inflammatory gene expression, with impaired inflammation resolution.
- Immune cell analysis revealed reduced naive T/B cells and increased monocytes and exhausted NK cells in older adults.
- Reactivation of latent viruses (HSV, CMV) was observed in the upper airways of older patients.
Conclusions:
- Aging causes significant immune dysregulation at multiple levels (transcriptional, protein, cellular) in COVID-19 patients.
- Age-dependent inflammatory imbalances and impaired immune resolution contribute to severe disease.
- Findings suggest novel therapeutic targets for mitigating age-related COVID-19 severity.
Abstract:
Age is a major risk factor for severe coronavirus disease-2019 (COVID-19), yet the mechanisms responsible for this relationship have remained incompletely understood. To address this, we evaluated the impact of aging on host and viral dynamics in a prospective, multicenter cohort of 1,031 patients hospitalized for COVID-19, ranging from 18 to 96 years of age. We performed blood transcriptomics and nasal metatranscriptomics, and measured peripheral blood immune cell populations, inflammatory protein expression, anti-SARS-CoV-2 antibodies, and anti-interferon (IFN) autoantibodies. We found that older age correlated with an increased SARS-CoV-2 viral load at the time of admission, and with delayed viral clearance over 28 days. This contributed to an age-dependent increase in type I IFN gene expression in both the respiratory tract and blood. We also observed age-dependent transcriptional increases in peripheral blood IFN-γ, neutrophil degranulation, and Toll like receptor (TLR) signaling pathways, and decreases in T cell receptor (TCR) and B cell receptor signaling pathways. Over time, older adults exhibited a remarkably sustained induction of proinflammatory genes (e.g., CXCL6) and serum chemokines (e.g., CXCL9) compared to younger individuals, highlighting a striking age-dependent impairment in inflammation resolution. Augmented inflammatory signaling also involved the upper airway, where aging was associated with upregulation of TLR, IL17, type I IFN and IL1 pathways, and downregulation TCR and PD-1 signaling pathways. Metatranscriptomics revealed that the oldest adults exhibited disproportionate reactivation of herpes simplex virus and cytomegalovirus in the upper airway following hospitalization. Mass cytometry demonstrated that aging correlated with reduced naïve T and B cell populations, and increased monocytes and exhausted natural killer cells. Transcriptional and protein biomarkers of disease severity markedly differed with age, with the oldest adults exhibiting greater expression of TLR and inflammasome signaling genes, as well as proinflammatory proteins (e.g., IL6, CXCL8), in severe COVID-19 compared to mild/moderate disease. Anti-IFN autoantibody prevalence correlated with both age and disease severity. Taken together, this work profiles both host and microbe in the blood and airway to provide fresh insights into aging-related immune changes in a large cohort of vaccine-naïve COVID-19 patients. We observed age-dependent immune dysregulation at the transcriptional, protein and cellular levels, manifesting in an imbalance of inflammatory responses over the course of hospitalization, and suggesting potential new therapeutic targets.
More Related Videos
12:21A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness
Published on: September 28, 2022
07:58Quantitative Imaging of Lineage-specific Toll-like Receptor-mediated Signaling in Monocytes and Dendritic Cells from Small Samples of Human Blood
Published on: April 16, 2012